NCT03208972View on ClinicalTrials.gov

Elonva in Combination With Hp-FSH Versus Elonva With Low Dose hCG

PHASE4CompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Infertility
Interventions
DRUG

low dose hCG

DRUG

hp-FSH

DRUG

Corifollitropin Alfa

"Corifollitropin Alfa (Elonva) dosage depending on weight, once administered first day of ovarian stimulation for all subjects, and on day 7 they proceed with the treatment of the allocated group.~\<60 kg: Elonva 100 MCG \> 60 kg: Elonva 150 MCG"

Trial Locations (1)

9000

AZ Jan Palfijn, Ghent

All Listed Sponsors
collaborator

Onze Lieve Vrouw Hospital

OTHER

lead

AZ Jan Palfijn Gent

OTHER

NCT03208972 - Elonva in Combination With Hp-FSH Versus Elonva With Low Dose hCG | Biotech Hunter | Biotech Hunter